CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...